PMR Insight: Sanofi/Zentiva’s products led the field among reimbursed Rx and OTC drugs in Slovakia in 2016

Justyna Zagórska, Pharmaceutical Market Analyst
The ranking of the 30 best-selling reimbursed drugs in Slovakia in 2016 (in terms of volume) was led by Sanofi, the prominent innovative concern, and Zentiva, its generic division. The two companies have ten products on the list, with Novalgin 500 mg by Sanofi and Agen 5 by Zentiva taking the two leading positions in the table. Last year Slovaks purchased 1.48 million packets of the former product and 780,000 packets of the latter. The two drugs were reimbursed to the tune of €3.4m and €0.6m respectively. Zentiva products also headed the best-selling OTC drug ratings, taking the top two places:…

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.